Cytokinetics Inc (CYTK)
51.48
-0.34
(-0.66%)
USD |
NASDAQ |
Nov 04, 16:00
51.50
+0.02
(+0.04%)
After-Hours: 20:00
Cytokinetics Debt to Equity Ratio: 6.034 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.034 |
| March 31, 2024 | -1.560 |
| December 31, 2023 | -1.598 |
| September 30, 2023 | -1.388 |
| June 30, 2023 | -1.830 |
| March 31, 2023 | -2.666 |
| December 31, 2022 | -5.659 |
| September 30, 2022 | -38.09 |
| June 30, 2022 | 1.768 |
| March 31, 2022 | 1.683 |
| December 31, 2021 | 0.5857 |
| September 30, 2021 | 0.5661 |
| June 30, 2021 | 8.438 |
| March 31, 2021 | 2.025 |
| December 31, 2020 | 1.197 |
| September 30, 2020 | 0.8958 |
| June 30, 2020 | -1.695 |
| March 31, 2020 | -2.861 |
| December 31, 2019 | -11.82 |
| September 30, 2019 | -2.253 |
| June 30, 2019 | -9.084 |
| March 31, 2019 | 12.63 |
| December 31, 2018 | 1.635 |
| September 30, 2018 | 0.8048 |
| June 30, 2018 | 0.4306 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.3208 |
| December 31, 2017 | 0.2893 |
| September 30, 2017 | 0.2061 |
| June 30, 2017 | 0.1723 |
| March 31, 2017 | 0.3147 |
| December 31, 2016 | 0.3167 |
| September 30, 2016 | 0.3573 |
| June 30, 2016 | 0.6073 |
| March 31, 2016 | 0.5089 |
| December 31, 2015 | 0.2134 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-38.09
Minimum
Sep 2022
8.438
Maximum
Jun 2021
-2.420
Average
-1.388
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Alnylam Pharmaceuticals Inc | 31.64 |
| Biomarin Pharmaceutical Inc | 0.1098 |
| Catalyst Pharmaceuticals Inc | 0.00 |
| Sarepta Therapeutics Inc | 1.139 |
| Ocugen Inc | 0.1688 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.524B |
| Total Liabilities (Quarterly) | 1.415B |
| Shareholders Equity (Quarterly) | 108.55M |
| Current Ratio | 10.39 |
| Net Debt Paydown Yield | -0.14% |